Skip to content

Checked

Class IIDrug recallOngoing

Acetaminophen recall

Recalled by Aero Healthcare of Valley Cottage, NY · FDA report 11/12/2025

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class II
Moderate
Status
Ongoing
Recall started
10/17/2025
Distribution
Nationwide

Reason for recall

Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product
Acetaminophen 500mg Caffeine 65mg caplets, packaged as 2 caplets per packet further packaged in a 50-count box, AERO TAB, Manufactured for AERO HEALTHCARE US, Valley-Cottage, NY, 10989, NDC 55305-135-01
Lot and code info
Lot # 9282, Exp Date: 2026-09-01; Lot # 9310, Exp Date: 2026-11-01
Brand names
AEROTAB PAIN RELIEVER
Recall number
D-0155-2026
Event ID
97809
Initiated by
Voluntary: Firm initiated

Where it was distributed

US Nationwide.

  • Nationwide

Recall timeline

  1. 10/17/2025Firm started the recall
  2. 11/05/2025FDA classified it as Class II
  3. 11/12/2025Published in the FDA enforcement report

Frequently asked questions

Why was Acetaminophen recalled?
Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.
What does Class II mean?
Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Where was the recalled product sold?
US Nationwide.
Is this recall still active?
The FDA lists the recall as ongoing. The recall is still in progress.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 11/12/2025 · Do not rely on openFDA to make decisions regarding medical care